Français
ItalianoBond Bristol Myers Squibb 0% ( USU11009BF03 ) in USD
| Issuer | Bristol Myers Squibb | ||||||||
| Market price | 100.00 % ⇌ | ||||||||
| Country |  United States
|
||||||||
| ISIN code |
 USU11009BF03 ( in USD )
|
||||||||
| Interest rate | 0% | ||||||||
| Maturity | 16/05/2022 - Bond has expired | ||||||||
|
Prospectus brochure in PDF format |
|||||||||
| Minimal amount | 2 000 USD | ||||||||
| Total amount | 500 000 000 USD | ||||||||
| Cusip | U11009BF0 | ||||||||
| Detailed description |
Bristol Myers Squibb is a global biopharmaceutical company engaged in the research, development, and marketing of innovative medicines and biotherapeutics across various therapeutic areas, including oncology, cardiovascular disease, immunology, and fibrosis. Bristol Myers Squibb's US$500,000,000 0% bond (CUSIP: U11009BF0, ISIN: USU11009BF03), issued in the United States, matured on May 16, 2022, and has been redeemed at 100% of face value. |
||||||||
| |||||||||